ViroCell Biologics ("ViroCell" or the "Company"), a specialist viral vector Contract Development and Manufacturing Organisation ("CDMO") for cell and gene therapy (CGT) clinical trials, announces the ...

The main problem is that most vector production technologies were developed for the lab, rather than to support industrial ...

Strategic appointments advance Addgene’s growth and market expansion strategyWATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- Addgene, an organization empowering discovery by providing scientists ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...